Arrow Financial’s Alexion Pharmaceuticals ALXN Stock Holding History

Arrow Financial’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-240	Closed	-$44K	–	340
2021 Q2	$44K	Hold	240	–	–	0.01%	226
2021 Q1	$37K	Hold	240	–	–	﹤0.01%	231
2020 Q4	$37K	Hold	240	–	–	0.01%	217
2020 Q3	$27K	Hold	240	–	–	0.01%	227
2020 Q2	$27K	Sell	240 -60	-20%	-$6.37K	0.01%	235
2020 Q1	$27K	Hold	300	–	–	0.01%	236
2019 Q4	$32K	Hold	300	–	–	0.01%	246
2019 Q3	$29K	Sell	300 -2,000	-87%	-$225K	0.01%	247
2019 Q2	$301K	Hold	2,300	–	–	0.06%	150
2019 Q1	$311K	Buy	2,300 +300	+15%	+$37.3K	0.07%	149
2018 Q4	$195K	Hold	2,000	–	–	0.05%	157
2018 Q3	$278K	Buy	+2,000	New	+$251K	0.06%	157

Other funds holding ALXN

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return